A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line
- 22 January 1993
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1180 (3) , 277-282
- https://doi.org/10.1016/0925-4439(93)90050-b
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Molecular dosimetry of sister chromatid exchange induction in 9L cells treated with 6-thioguanineMutagenesis, 1991
- Studies on the incorporation of precursors into purine and pyrimidine nucleotides via ‘de novo’ and ‘salvage’ pathways in normal lymphocytes and lymphoblastic cell-line cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Purification, characterization, and kinetic analysis of inosine 5′-monophosphate dehydrogenase of Tritrichomonas foetusMolecular and Biochemical Parasitology, 1987
- Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblastsBiochemical Pharmacology, 1986
- High-performance liquid chromatographic assay for identification and quantitation of nucleotides in lymphocytes and malignant lymphoblastsJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Differential chromatid damage induced by 6-thioguanine in CHO cellsExperimental Cell Research, 1981
- Biochemical commitment to replication in cancer cellsAdvances in Enzyme Regulation, 1980
- Reversal of the growth inhibitory effects of 6-methylthiopurine ribonucleosideBiochemical Pharmacology, 1970
- The inhibition of nucleic acid synthesis by mycophenolic acidBiochemical Journal, 1969
- Metabolism of Thiopyrimidines and ThiopurinesJournal of Biological Chemistry, 1963